Concepedia

Author

Yongxing Bao

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID

Also Known As

Bao Y, Y Bao, Y G Bao, Y. Bao, Yong-Xing Bao, Yong-xing Bao, Yongxing Bao

59

Publications

351

Citations

12

H-Index

26

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical CollegeNational Cancer CenterFirst Affiliated Hospital Zhejiang UniversityFirst Affiliated Hospital of Xinjiang Medical UniversityWest China Hospital of Sichuan University
YB

About

Yongxing Bao is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, cancer research, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

89

2

Health Sciences

2

2

40

3

Cell Biology

1

1

49

4

Immunology

1

1

49

5

Pathology

1

1

24

Yongxing Bao

×

13

Publications

253

Citations

11

H-Index

YearCitations

Chemokine (C-C motif) ligand 21/C-C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial-mesenchymal transition via the extracellular signal-regulated kinase signaling pathway

Guangxin Zhong, Lu Chen, Ruihong Yin,

Molecular Medicine Reports

2017

49

Anlotinib Enhances the Antitumor Activity of High‐Dose Irradiation Combined with Anti‐PD‐L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer

Meng Yuan, Yirui Zhai, Yu Men,

Oxidative Medicine and Cellular Longevity

2022

33

Predictive Impact of Common Variations in DNA Repair Genes on Clinical Outcome of Osteosarcoma

Shengbin Bai, Hongxiang Chen, Yongxing Bao,

Asian Pacific Journal of Cancer Prevention

2013

24

Risk of cardiac‐related mortality in stage <scp>IIIA‐N2</scp> non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database

Xin Sun, Yu Men, Jianyang Wang,

Thoracic Cancer

2021

20

Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the <scp>PORT‐C</scp> randomized controlled trial

Zeliang Ma, Bin Liang, Ran Wei,

Thoracic Cancer

2023

18

The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients

Meng Yuan, Yongxing Bao, Zeliang Ma,

Frontiers in Oncology

2021

17

Postoperative radiotherapy improves survival of patients with <scp>ypN2</scp> non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database

Yongxing Bao, Xu Yang, Yu Men,

Thoracic Cancer

2021

16

Higher Lung and Heart Doses Decrease Early and Long-Term Survival, Respectively, in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation

Zeliang Ma, Yunsong Liu, Yongxing Bao,

Advances in Radiation Oncology

2023

16

Survival prediction model for postoperative hepatocellular carcinoma patients

Zhihui Ren, Shasha He, Xiaotang Fan,

Medicine

2017

14

Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway

Songan Zhang, Wen Hong, Gulixian Tuluwengjiang,

Tumor Biology

2017

12

Page 1